Aims-To determine how the microbiology laboratories of one region process serological requests from patients with suspected infectious illness, referred to as "clinical syndrome" type patients in this study; to consider areas where improvement in the associated serology service could be made. Methods-A prospective two month collection of data on all serological requests from patients with suspected infectious illness was undertaken. A questionnaire on laboratory policieslprocedures was also completed by the 10 departments taking part. Results-Serology specimens from "clinical syndrome" patients accounted for 1-2% oftotal microbiology samples. There was significant variation in some of the policies/procedures carried out by the 10 laboratories when handling serological requests. Differences were seen in the use of laboratory protocols for test processing, range of tests performed, demand for second (convalescent) serum samples, storage of serum samples, and reporting of results. Conclusions-The laboratory management of "clinical syndrome" type requests is complex. Individual pathology departments vary in the way they handle serology specimens but this study highlighted areas which may contribute to improving the appropriateness oftesting and the more efficient use of serology resources. These include improving (1) clinician education, (2) pathology request forms to encourage better clinical information, (3) appropriate laboratory protocols to ald decision making on test selection, (4) percentage of convalescent serum samples received together with longer serum sample storage, and (5) turnround times of serology reports. (7 Clin Pathol 1995;48:358-363) 
Over the past decade, there has been an increasing awareness and analysis of the appropriateness of laboratory tests. This has been stimulated by concern over both increasing costs of testing and a desire to improve the overall use of pathology services.' To date, such studies have mainly been carried out by haematology2 or biochemistry' departments where requests and tests are more easily defined and where increasing automation of laboratory methods permits easier systematic analysis of the tests performed. In microbiology laboratories a review of requests received and subsequent tests performed is more complex. Compared with haematology and biochemistry departments, there is often a greater need to interpret the clinical information given before deciding on which laboratory tests to perform. Results of primary testing may also stimulate the need for secondary tests. In no area is this more important than with blood samples received for serological examination.
All clinical microbiology laboratories across the United Kingdom will receive serum samples from patients who have presented to clinicians with a "clinical syndrome" suggestive of a possible underlying infectious disease, where the diagnosis requires serological investigations. The types of disease falling into this description can be relatively well-defined-for example, atypical pneumonia, or can be broad and vague-for example, post-viral illness. However, these types of clinical problem often need serological testing against a range of microorganisms including virological (Epstein-Barr, influenzae, coxsackie), bacteriological (Legionella, Mycoplasma) and parasitological (Toxoplasma) pathogens. When samples are received from such patients it may be difficult to decide on the most appropriate tests to perform. The information given on the request form is critical to the decision making process and the quality ofthat information is often poor. Even the basic completion of a patient's name, date of birth and sex can influence subsequent processing. After patient identification has been considered, clinical details are critical and for virtually all serological tests, knowledge of the date of onset of illness is vital.
The decision on which tests to perform on "clinical syndrome" requests often falls to the microbiology laboratory and although this type of request comprises only a small percentage of overall specimen numbers, it may generate a significant amount ofwork for both laboratory and medical staff within the departnent. In an attempt to analyse how microbiology departments process such serological requests and to look for potential ways of improving the service, a study was undertaken in 10 district laboratories of the Oxford region.
Questionnaire on serological testing of infectious "clinical syndrome" requests Total number of specimens processed in microbiology annually Total number of specimens processed in virology/serology during 2 month period of study Total number of "clinical syndrome" requests processed during 2 month period of study What happens to "clinical syndrome" requests after arrival in the laboratory? How are decisions made on which tests to perform? a) Are there laboratory protocols for specific "clinical syndromes" described? b) Are requests reviewed by MLSO Total number of specimens processed in microbiology dept.
-t 113000 158000 131 000 165000 37000 92000 24000 110000 116000 annually Total number of specimens processed in virology/serology 50000 17000 31 000 18500 11100 5000 22800 8200 22000 18000 section of dept. annually* Total number of "clinical syndrome" requests annually results (including those from reference laboratories) sent to the clinician. 14 With the investigations performed, has a significant positive result been found?
A list of specimens and requests commonly received by virology/serology laboratories, but to be excluded from the study, was also distributed. This comprised the following: all swabs/aspirates for viral culture/antigen testing; other miscellaneous material (for example, cerebrospinal fluid, faeces) sent for viral culture/ antigen testing; all antenatal serology; all hepatitis B vaccination associated serology; all hepatitis B antigen screening-for example, predialysis, preoperation; all specific HIV and syphilis serology requests originating from Genito-urinary clinics, insurance requirements, etc.; all "immunological" type requests-for example, complement levels, C-reactive protein; and all chlamydial culture/antigen tests.
All data was returned to the author one month after the period of study to allow for the arrival of convalescent serum samples from requests received in July.
Results
The results from the questionnaire arm of the study were as follows:
Questions 1-3-"Clinical syndrome" requests comprise 8 A summary of the prospective data collected by the 10 departments for the second part of the study is given in table 4. One laboratory was unable to provide the majority of data requested because of staffing difficulties during the study period. (7), Influenzae A+ B (7), Q fever (7), Chlamydia (7), Adenovirus (5), Epstein-Barr virus (2), Cytomegalovirus (2), Legionella (1), Mumps (1), Anti-streptolysin 0 titre (1) the laboratories rarely contacted a clinician (<5% ofrequests) whereas in two units, doctors were consulted regarding approximately 30% and 50% ofspecimens. Investigations requiring second serum samples varied from 15 to 79% (average 42%) but when a convalescent sample had been asked for, only one laboratory obtained a 50% response (average 35%). There was also a failure to obtain further clinical details with the second serum sample in 65-100% of cases. Laboratories 1 and 3 perform most serological investigations in-house as they are also Public Health Laboratories. Laboratory 6 is a small unit sending nearly all serology to laboratory 1. Laboratory 8, although small, is a more self-sufficient unit as it handles military source specimens. The other six departments are similar in terms ofrepresenting large district laboratories which require the help of secondary reference units for some serological tests. The ratio of tests performed within the primary laboratory and those sent to reference laboratories was remarkably consistent at a ratio of 1: 1 across these six districts. From the data collected by most units, it was possible to calculate the average time taken to complete investigations on a "clinical syndrome" request for both in-house and reference serology. An average of 6-5 days was taken to complete in-house investigations whilst work requiring reference testing took an average of 20-2 days. The number of "clinical syndrome" requests producing a significant positive result varied across the region with some laboratories achieving over double the rate of others (average 12%).
Discussion
Over recent years there have been several studies of the use of hospital clinical laboratories45 and in particular the appropriateness of tests carried out and the efficiency ofresources available. Serology is not a discipline that has received much attention but most clinical microbiologists throughout the United Kingdom will be only too aware of the intrinsic problems that their serological workload presents. The most difficult aspect is the processing of requests from patients with "clinical syndromes" suggestive of possible infectious disease.
Clinicians vary greatly in their test ordering behaviour. One publication listed 32 different reasons for ordering a test including "frustration at nothing else to do".6 When clinicians face patients complaining of vague symptoms such as general malaise or myalgia/arthralgia, there is an almost automatic tendency for a serum sample to be taken for "viral titres". This study is the first to attempt to show how clinical laboratories in one region manage such requests.
As expected, "clinical syndrome" requests contributed a fraction to the total of microbiology specimens and even within the serology section itself, these samples formed a small minority of overall numbers. For "clinical syndrome" requests basic patient details may influence which tests are performed. A return from two laboratories of less than 90% adequately completed patient details was unsatisfactory. The use of laboratory protocols for serology tests has advantages and disadvantages. Their application can lessen the need for more detailed clinical information and can improve the efficiency of the laboratory but they may encourage increased unnecessary testing because they are by definition designed for an average patient.7 Protocols or guidelines are more likely to succeed if they are agreed jointly by laboratory staff and clinicians, with regular review, but achieving consensus on the criteria for whether a test is appropriate for a particular clinical setting is problematic. Progress, however, can be achieved and in the author's own district, following discussions with relevant clinical colleagues, laboratory guidelines have been drawn up for the most appropriate tests to be performed on patients with a history of influenza-like illness followed by arthralgia, one ofthe most common "clinical syndrome" type requests. Clinician education in the use of the laboratory, in the form of lectures, seminars or guidelines, has been proposed as the most promising long term approach to influencing test ordering behaviour.8
Many clinicians are unaware of how best to investigate, which tests to order and how much clinical information to give the laboratory especially on "clinical syndrome" type patients. The finding that 50% of forms asked for "viral titres" demonstrates clinicians' ignorance and highlights the responsibility given to laboratories as the clinician has, in effect, passed over decision making on appropriate investigations to the laboratory.
In this study two units declared that serological testing would not be performed solely on acute serum samples; such a policy must undoubtedly result in missed diagnoses. In another department, investigations are carried out on every sample which must lead to a number of inappropriate tests with the added concern that single titre results could mislead the clinician. A review of both these extremes of practice was advised in the departments concerned. Storage space is the obvious limiting factor for determining how long laboratories are able to keep serum samples. However, the occasional need to re-examine serum samples is so important that all laboratories should be encouraged to store serum samples for a minimum of six months and preferably one year. The percentage of requests quoting a date of onset of illness was disappointingly low in this study. Knowledge of the date of onset of a suspected infectious illness is often critical not only for making decisions on which tests to perform but also on the interpretation of subsequent results. A simple amendment to the request form, specifically asking for a date of onset should improve this response.
Acute serum samples from some "clinical syndrome" type patients will inevitably become redundant as subsequent clinical events or other investigations reveal a diagnosis, but testing ofpaired serum samples in parallel is almost obligatory for the diagnosis of some infections.
In this study 50% oflaboratories took no action if second serum samples failed to arrive. This indoubtedly contributed to the poor response seen to second serum sample requests (average 35%). Additional clinical details rarely accompanied the second serum sample but only half of the laboratories specifically asked clinicians for further information. As a consequence, departments were urged to review their procedures both in the way they request second serum samples and the action taken when convalescent samples fail to arrive. A second serum sample response rate of 50%, achieved by one unit, should be an attainable goal, and the development ofcomputer systems for requesting, processing and reporting tests9 should improve this response further in the future. Most serological investigations are performed in batches and testing within the primary unit will depend on individual laboratory working practices. Results from this study show that an average turnround time of under seven days is possible. When serum samples are despatched to reference laboratories, the turnround time is significantly extended. In this survey three units achieved an average time of 19 days for dispatched samples whilst four other departments took 21 to 22 days. The latter group were encouraged to review their dispatch procedures as a potential improvement of two to three days seemed achievable.
The majority of "clinical syndrome" requests will not detect any significant abnormality but it is not known whether an average positive result rate of 12% is acceptable as similar analyses on serological testing have not been published. The finding that some units obtained positive result rates two to three times greater than others may, in part, be because of different subjective interpretations of serological results. For example, different laboratories may have interpreted a significant positive result as (1) any positive titre to any antigen, (2) a single titre above "normal", or (3) a rising titre to an organism likely to have caused the illness specified. The wide variation in positive result rates also suggests that improvements in the range and performance of relevant tests and the ability to gather more precise information from clinicians together with more convalescent specimens are all areas ofthe serology service which need review.
In biochemistry departments in particular, it has been shown that laboratories respond differently to the same clinical request.'0 The production ofprompt reliable laboratory results will contribute little to patient outcome if the tests performed are clinically inappropriate or redundant and the efficient use of pathology resources is diminished. This study is the first to analyse the processing of serology specimens in an area of particular difficulty for clinical microbiologists and their departments. Use of the serology service, as applied to "clinical syndrome" type problems, has been described within 10 departments in the Oxford region and practices in need of review and improvement have been highlighted. This study is likely to be representative of many serology departments across the country and it is hoped that the findings may stimulate other laboratories to analyse the procedures and outcomes for similar areas of their work.
